SILu(TM)MAb Infliximab Stable-Isotope Labeled Monoclonal Antibody

Descrição detalhada : SILu(TM)MAb Infliximab Stable-Isotope Labeled Monoclonal Antibody (MSQC9) is a recombinant, stable isotope-labeled, monoclonal antibody which incorporates [13C6, 15N4]-Arginine and [13C6, 15N2]-Lysine. Expressed in CHO cells, it is designed to be used as an internal standard for the quantitative mass spectrometry analysis of Infliximab in human serum. Infliximab is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-a) and is used to treat autoimmune diseases.Infliximab has been approved for the treatment of Crohn's disease, ulcerative colitis, psoriasis, psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis. SILu(TM)MAb Infliximab Stable-Isotope Labeled Monoclonal Antibody is for R&D use only. Not for drug, household, or other uses.
Sinónimos : Mass spectrometry standard, Infliximab; SIL Infliximab; Stable isotope labelled Infliximab
Armazenamento : -20C
Embalagem : 1X1EA